BFA
ADMA icon

BlackRock Fund Advisors’s ADMA Biologics ADMA Stock Holding History

BlackRock Fund Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$93K Buy
18,213
+176
+1% +$1.01K ﹤0.01% 3626
2016
Q3 		$131K Buy
18,037
+8,360
+86% +$53.1K ﹤0.01% 3567
2016
Q2 		$58K Buy
9,677
+9,114
+1,619% +$63.8K ﹤0.01% 3790
2016
Q1 		$5K Buy
563
+154
+38% +$880 ﹤0.01% 4080
2015
Q4 		$3K Buy
+409
New +$3.68K ﹤0.01% 4212

Other funds holding ADMA

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

BlackRock Fund Advisors's ADMA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its ADMA Biologics (ADMA) stake by 0.98% in Q4 2016, buying an estimated $1.01K and bringing the position to 18,213 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #3626.

BlackRock Fund Advisors first reported a position in ADMA in Q4 2015 and has held it in 5 quarters since. The position peaked at $131K in Q3 2016. 18 funds tracked by Wall St. Rank hold ADMA as of Q4 2016.

  • BlackRock Fund Advisors held 18,213 shares of ADMA Biologics worth $93K as of Q4 2016.
  • BlackRock Fund Advisors bought 176 ADMA Biologics shares in Q4 2016, an estimated $1.01K.
  • ADMA Biologics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3626 holding.
  • BlackRock Fund Advisors first reported a position in ADMA Biologics in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Fund Advisors's ADMA Biologics position peaked at $131K in Q3 2016.
  • 18 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.